for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Geron Reports Q4 Loss Per Share Of $0.15

March 12 (Reuters) - Geron Corp:

* ORATION REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND 2020 MILESTONES

* Q4 LOSS PER SHARE $0.15

* Q4 EARNINGS PER SHARE ESTIMATE $-0.20 -- REFINITIV IBES DATA

* Q4 REVENUE $171,000

* Q4 REVENUE ESTIMATE $73,200 -- REFINITIV IBES DATA

* SAYS TOPLINE RESULTS FROM PHASE 3 IMERGE CLINICAL TRIAL EXPECTED BY MID-YEAR 2022

* EXPECTS $159.2 MILLION IN CASH AND MARKETABLE SECURITIES AT YEAR-END 2019 WILL BE SUFFICIENT IN 2020 TO CONTINUE TO FUND IMERGE AND COMMENCE PROOF OF CONCEPT STUDY Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up